Telix PharmaceuticalsTLX
13F holders, Q4 2024 (December 31)1holders
$15.40avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Telix Pharmaceuticals Ltd. (TLX) in their 13F filings. The largest holder was UBS Group AG ($57K).
- Company
- Telix Pharmaceuticals Ltd.
- CUSIP
- 87961M105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $57K |
| Exits | 0 | $0 |
Ownership 1 holders
| UBS Group AG | 0.00% | New | 3,730 | $57K |
"% of holder's portfolio" is TLX's weight in each manager's 13F, not the share of Telix Pharmaceuticals Ltd. the manager owns.